SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 324 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $92,286,000 | +13.9% | 471,592 | -1.1% | 0.07% | +5.9% |
Q2 2020 | $81,000,000 | +50.7% | 476,692 | +2.4% | 0.07% | +19.3% |
Q1 2020 | $53,732,000 | +26.2% | 465,692 | +25.0% | 0.06% | +29.5% |
Q4 2019 | $42,572,000 | +33.7% | 372,592 | -0.1% | 0.04% | +29.4% |
Q3 2019 | $31,845,000 | +25.6% | 372,892 | +1.8% | 0.03% | +25.9% |
Q2 2019 | $25,359,000 | -7.2% | 366,400 | -1.8% | 0.03% | -10.0% |
Q1 2019 | $27,326,000 | +33.6% | 373,100 | +3.4% | 0.03% | +15.4% |
Q4 2018 | $20,454,000 | -25.0% | 361,000 | +2.1% | 0.03% | -13.3% |
Q3 2018 | $27,270,000 | +12.6% | 353,600 | -3.1% | 0.03% | +7.1% |
Q2 2018 | $24,219,000 | +32.5% | 364,800 | +4.5% | 0.03% | +27.3% |
Q1 2018 | $18,272,000 | -7.0% | 349,100 | -4.9% | 0.02% | +4.8% |
Q4 2017 | $19,645,000 | -1.7% | 367,200 | 0.0% | 0.02% | -8.7% |
Q3 2017 | $19,979,000 | +6.1% | 367,200 | +0.9% | 0.02% | +4.5% |
Q2 2017 | $18,823,000 | -14.7% | 363,800 | +3.6% | 0.02% | -18.5% |
Q1 2017 | $22,064,000 | +51.7% | 351,000 | +27.4% | 0.03% | +17.4% |
Q4 2016 | $14,543,000 | +58.0% | 275,600 | +61.7% | 0.02% | +53.3% |
Q3 2016 | $9,203,000 | +28.0% | 170,400 | -4.2% | 0.02% | +25.0% |
Q2 2016 | $7,189,000 | +13.6% | 177,900 | -4.7% | 0.01% | 0.0% |
Q1 2016 | $6,327,000 | -2.3% | 186,700 | +29.4% | 0.01% | -25.0% |
Q4 2015 | $6,476,000 | +16.4% | 144,300 | 0.0% | 0.02% | +14.3% |
Q3 2015 | $5,564,000 | -1.7% | 144,300 | +23.4% | 0.01% | -6.7% |
Q2 2015 | $5,658,000 | +37.4% | 116,900 | +0.3% | 0.02% | +36.4% |
Q1 2015 | $4,118,000 | +11.4% | 116,500 | +1.3% | 0.01% | -21.4% |
Q4 2014 | $3,695,000 | -11.4% | 115,000 | +2.5% | 0.01% | -12.5% |
Q3 2014 | $4,172,000 | -4.6% | 112,200 | -1.8% | 0.02% | 0.0% |
Q2 2014 | $4,372,000 | -16.1% | 114,300 | 0.0% | 0.02% | -20.0% |
Q1 2014 | $5,208,000 | +47.7% | 114,300 | +29.3% | 0.02% | +42.9% |
Q4 2013 | $3,526,000 | -8.5% | 88,400 | +0.6% | 0.01% | -12.5% |
Q3 2013 | $3,853,000 | +33.3% | 87,900 | -4.4% | 0.02% | +23.1% |
Q2 2013 | $2,891,000 | – | 91,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |